Table 2 Enzyme inhibitory effects of the tested extracts.

From: Enhancing bioactivity and bioavailability of Limonium bellidifolium via cyclodextrin-based inclusion complexes: a new strategy in drug discovery from halophyte source

Samples

AChE inhibition (mg GALAE/g)

BChE inhibition (mg GALAE/g)

Amylase inhibition (mmol ACAE/g)

Glucosidase inhibition (mmol ACAE/g)

Tyrosinase inhibition (mg KAE/g)

1-L.bellidifolium AP α-CD 25

0.88 ± 0.10

na

0.10 ± 0.01

5.34 ± 0.00

48.89 ± 4.01

2-L.bellidifolium AP α-CD 40

1.22 ± 0.18

na

0.10 ± 0.01

5.19 ± 0.17

50.92 ± 0.04

3-L.bellidifolium AP α-CD 60

0.95 ± 0.02

na

0.11 ± 0.01

5.10 ± 0.46

52.10 ± 2.21

4-L.bellidifolium R α-CD 25

2.25 ± 0.22

na

0.16 ± 0.04

5.35 ± 0.06

74.11 ± 1.21

5-L.bellidifolium R α-CD 40

2.05 ± 0.19

na

0.13 ± 0.02

5.23 ± 0.28

75.57 ± 3.04

6-L.bellidifolium R α-CD 60

1.62 ± 0.19

na

0.11 ± 0.02

5.13 ± 0.46

71.30 ± 2.48

7-L.bellidifolium AP β-CD 25

1.32 ± 0.19

na

0.10 ± 0.02

5.34 ± 0.00

65.07 ± 1.09

8-L.bellidifolium AP β-CD 40

1.60 ± 0.04

na

0.10 ± 0.01

4.44 ± 0.20

66.07 ± 0.62

9-L.bellidifolium AP β-CD 60

1.24 ± 0.37

na

0.10 ± 0.06

5.35 ± 0.01

48.26 ± 1.40

11-L.bellidifolium R β-CD 25

2.44 ± 0.32

na

0.19 ± 0.01

5.40 ± 0.01

85.33 ± 0.54

11-L.bellidifolium R β-CD 40

2.03 ± 0.19

na

0.12 ± 0.02

5.29 ± 0.11

67.21 ± 1.44

12-L.bellidifolium R β-CD 60

1.86 ± 0.20

0.12 ± 0.93

0.12 ± 0

4.95 ± 0.39

67.09 ± 0.88

13-L.bellidifolium AP

4.07 ± 0.10

1.86 ± 1.40

0.96 ± 0.04

5.35 ± 0.01

129.56 ± 1.31

14-L.bellidifolium R

4.85 ± 0.07

4.26 ± 0.79

0.89 ± 0.05

5.37 ± 0.17

135.83 ± 0.33

  1. *Values are reported as mean ± SD of three parallel measurements. GALAE Galantamine equivalent, KAE Kojic acid equivalent, ACAE Acarbose equivalent, AP aerial part, R root part, α -CD α cyclodextrin, β-CD β cyclodextrin, na not active.